Clinical Trials Logo

Refractive Errors clinical trials

View clinical trials related to Refractive Errors.

Filter by:

NCT ID: NCT06053736 Completed - Clinical trials for Refractive Ametropia

1-Week Dispensing Evaluation of REVIVEā„¢ Toric Soft Contact Lenses

Start date: October 4, 2023
Phase: N/A
Study type: Interventional

Experienced soft contact lens wearing subjects will be enrolled in this 1-week, post-market, bilateral, repeated measures, dispensing study. All subjects will be seen for a Screening/Dispensing Visit at which informed consent will be obtained and eligibility will be assessed. If subjects satisfy all eligibility criteria and none of the exclusion criteria, subjects will be fit and dispensed study lenses. If unsuccessful in the dispensed lenses, additional lenses may be trialed. Once vision and lens fit are determined to be acceptable, eligible subjects will wear study lenses in both eyes for at least 8 hours per day (with the exception of the follow-up visits where the lenses should be worn for a minimum of 2 hours), for approximately 1 week (7 days +/-3 days). Measurements will be taken at the insertion visit and at the 7-day follow-up visit.

NCT ID: NCT06052046 Recruiting - Astigmatism Clinical Trials

Total30 for Astigmatism Contact Lenses

Start date: October 15, 2023
Phase: N/A
Study type: Interventional

Determine if Total30 for Astigmatism contact lenses (CLs) provide a comfortable wearing experience all day. CL discomfort affects most CL wearers with discomfort consistently topping the reasons why established CL wearers drop out of CLs. In fact, studies have consistently found that the frequency of CL dropout is around 20% with this dropout frequency staying relatively stable over the past 20 plus years. This static frequency of CL dropout is surprising since there have been a number of dramatic soft CL innovations during this time frame (e.g., widely available daily disposable CLs, silicone hydrogel CL materials with high oxygen transmissibility, new CL surface coatings).

NCT ID: NCT06044948 Completed - Refractive Errors Clinical Trials

Clinical Assessment of a Daily Disposable Soft Silicone Hydrogel Contact Lens

Start date: October 13, 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the clinical performance of DAILIES TOTAL1® spherical soft contact lenses over approximately 1 week of daily wear.

NCT ID: NCT06044688 Not yet recruiting - Astigmatism Clinical Trials

EyeQue VisionCheck 510(k) Clinical Trial

Start date: October 2023
Phase: N/A
Study type: Interventional

Demonstrate that refraction measurements from the device agree with refraction measurements from a phoropter within clinically meaningful limits.

NCT ID: NCT06021353 Recruiting - Refractive Errors Clinical Trials

Contralateral Study of WaveLight® Femtosecond Laser Devices for Corneal Flap Creation

Start date: October 20, 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the WaveLight Ultraviolet Femtosecond Laser System, Model 1026 (UV fs-Laser) corneal flap creation accuracy as compared to the already marketed WaveLight FS200 Infrared Femtosecond Laser, Model 1025 (IR fs-Laser).

NCT ID: NCT05992675 Enrolling by invitation - Refractive Errors Clinical Trials

Air Optix® Night and Day® Aqua Continuous Wear

Start date: October 5, 2023
Phase:
Study type: Observational

The purpose of this retrospective, Post-Market Clinical Follow-Up (PMCF) study is to assess the long term performance and safety of Air Optix® Night and Day® Aqua (AONDA) contact lenses in a real-world setting when worn as 30 days of continuous wear for vision correction.

NCT ID: NCT05976750 Enrolling by invitation - Myopia Clinical Trials

Air Optix® Night and Day® Aqua Daily Wear

Start date: October 3, 2023
Phase:
Study type: Observational

The purpose of this Post-Market Clinical Follow-Up (PMCF) study is to assess long term performance and safety of Air Optix® Night and Day® Aqua (AONDA) contact lenses in a real-world setting when worn as daily wear for vision correction.

NCT ID: NCT05964634 Not yet recruiting - Myopia Clinical Trials

Effect of Peripapillary Atrophy to Diagnose Glaucoma in High Myopia

Start date: August 1, 2023
Phase:
Study type: Observational

This study intends to analyze the characteristics between peripapillary retinal nerve fiber layer thickness and peripapillary area in high myopia with or without glaucoma

NCT ID: NCT05959200 Completed - Myopia Clinical Trials

Clinical Performance Evaluation of Two Frequent Replacement Silicone Hydrogel Toric Contact Lenses

Start date: August 14, 2023
Phase: N/A
Study type: Interventional

The primary objective of this study is to evaluate the axis orientation of LID226397 toric contact lenses.

NCT ID: NCT05957458 Completed - Myopia Clinical Trials

Myopia Control With Three Lever Irradiance of PBM Therapy in Children and Adults

MCPT
Start date: January 1, 2021
Phase: N/A
Study type: Interventional

Photobiomodulation therapy, that is, Low-level red-light technology provides a new and innovative myopia control approach. This strategy enables relatively high energies of light to be delivered at much shorter durations of exposure to induce the myopia control effect. The efficacy of the low-level red-light technology has been proven in a Chinese populationb for the recent 3 years with evidence based papers and amazing results. However, there's not yet evidence to demonstrate the relationship between the dose response effect of photobiomodulation therapy on myopia control at the different age lever.